This bifunctional molecule is a synthesized E3 ligase ligand-linker conjugate, incorporating a cereblon-binding thalidomide derivative. It serves as a key intermediate in constructing PROTACs for targeted protein degradation, a strategy widely applied in cancer and disease research in both cellular and preclinical models.
